Global Soft Capsules Drugs Market Research Report 2024(Status and Outlook)
Report Overview
Softgelcapsulesare typically a gelatin-based shell, containing a liquid. They can be used as a dosage form for a variety ofmedicines, including complementarymedicines, such as vitamins. In some cases, thesemedicinesmay have directions for use that say that they can or should be chewed.
This report provides a deep insight into the global Soft Capsules Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Soft Capsules Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Soft Capsules Drugs market in any manner.
Global Soft Capsules Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GSK
AstraZeneca
Boehringer Ingelheim
Vertex
Roche
Novartis
Teva
Chiesi
Sumitomo Dainippon
Merck
Atrium Innovations
Abbott
Blackmores
The Clorox Company
Nature Made
By-health
A&Z Pharmaceutical
Market Segmentation (by Type)
Liquid Core Drugs
Semi-solid Core Drugs
Market Segmentation (by Application)
Hospital Pharmacy
Retail Pharmacy
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Soft Capsules Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Softgelcapsulesare typically a gelatin-based shell, containing a liquid. They can be used as a dosage form for a variety ofmedicines, including complementarymedicines, such as vitamins. In some cases, thesemedicinesmay have directions for use that say that they can or should be chewed.
This report provides a deep insight into the global Soft Capsules Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Soft Capsules Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Soft Capsules Drugs market in any manner.
Global Soft Capsules Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GSK
AstraZeneca
Boehringer Ingelheim
Vertex
Roche
Novartis
Teva
Chiesi
Sumitomo Dainippon
Merck
Atrium Innovations
Abbott
Blackmores
The Clorox Company
Nature Made
By-health
A&Z Pharmaceutical
Market Segmentation (by Type)
Liquid Core Drugs
Semi-solid Core Drugs
Market Segmentation (by Application)
Hospital Pharmacy
Retail Pharmacy
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Soft Capsules Drugs Market
- Overview of the regional outlook of the Soft Capsules Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Soft Capsules Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Soft Capsules Drugs
1.2 Key Market Segments
1.2.1 Soft Capsules Drugs Segment by Type
1.2.2 Soft Capsules Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SOFT CAPSULES DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Soft Capsules Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Soft Capsules Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SOFT CAPSULES DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Soft Capsules Drugs Sales by Manufacturers (2019-2024)
3.2 Global Soft Capsules Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Soft Capsules Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Soft Capsules Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Soft Capsules Drugs Sales Sites, Area Served, Product Type
3.6 Soft Capsules Drugs Market Competitive Situation and Trends
3.6.1 Soft Capsules Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Soft Capsules Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 SOFT CAPSULES DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Soft Capsules Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SOFT CAPSULES DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 SOFT CAPSULES DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Soft Capsules Drugs Sales Market Share by Type (2019-2024)
6.3 Global Soft Capsules Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Soft Capsules Drugs Price by Type (2019-2024)
7 SOFT CAPSULES DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Soft Capsules Drugs Market Sales by Application (2019-2024)
7.3 Global Soft Capsules Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Soft Capsules Drugs Sales Growth Rate by Application (2019-2024)
8 SOFT CAPSULES DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Soft Capsules Drugs Sales by Region
8.1.1 Global Soft Capsules Drugs Sales by Region
8.1.2 Global Soft Capsules Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Soft Capsules Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Soft Capsules Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Soft Capsules Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Soft Capsules Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Soft Capsules Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GSK
9.1.1 GSK Soft Capsules Drugs Basic Information
9.1.2 GSK Soft Capsules Drugs Product Overview
9.1.3 GSK Soft Capsules Drugs Product Market Performance
9.1.4 GSK Business Overview
9.1.5 GSK Soft Capsules Drugs SWOT Analysis
9.1.6 GSK Recent Developments
9.2 AstraZeneca
9.2.1 AstraZeneca Soft Capsules Drugs Basic Information
9.2.2 AstraZeneca Soft Capsules Drugs Product Overview
9.2.3 AstraZeneca Soft Capsules Drugs Product Market Performance
9.2.4 AstraZeneca Business Overview
9.2.5 AstraZeneca Soft Capsules Drugs SWOT Analysis
9.2.6 AstraZeneca Recent Developments
9.3 Boehringer Ingelheim
9.3.1 Boehringer Ingelheim Soft Capsules Drugs Basic Information
9.3.2 Boehringer Ingelheim Soft Capsules Drugs Product Overview
9.3.3 Boehringer Ingelheim Soft Capsules Drugs Product Market Performance
9.3.4 Boehringer Ingelheim Soft Capsules Drugs SWOT Analysis
9.3.5 Boehringer Ingelheim Business Overview
9.3.6 Boehringer Ingelheim Recent Developments
9.4 Vertex
9.4.1 Vertex Soft Capsules Drugs Basic Information
9.4.2 Vertex Soft Capsules Drugs Product Overview
9.4.3 Vertex Soft Capsules Drugs Product Market Performance
9.4.4 Vertex Business Overview
9.4.5 Vertex Recent Developments
9.5 Roche
9.5.1 Roche Soft Capsules Drugs Basic Information
9.5.2 Roche Soft Capsules Drugs Product Overview
9.5.3 Roche Soft Capsules Drugs Product Market Performance
9.5.4 Roche Business Overview
9.5.5 Roche Recent Developments
9.6 Novartis
9.6.1 Novartis Soft Capsules Drugs Basic Information
9.6.2 Novartis Soft Capsules Drugs Product Overview
9.6.3 Novartis Soft Capsules Drugs Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 Teva
9.7.1 Teva Soft Capsules Drugs Basic Information
9.7.2 Teva Soft Capsules Drugs Product Overview
9.7.3 Teva Soft Capsules Drugs Product Market Performance
9.7.4 Teva Business Overview
9.7.5 Teva Recent Developments
9.8 Chiesi
9.8.1 Chiesi Soft Capsules Drugs Basic Information
9.8.2 Chiesi Soft Capsules Drugs Product Overview
9.8.3 Chiesi Soft Capsules Drugs Product Market Performance
9.8.4 Chiesi Business Overview
9.8.5 Chiesi Recent Developments
9.9 Sumitomo Dainippon
9.9.1 Sumitomo Dainippon Soft Capsules Drugs Basic Information
9.9.2 Sumitomo Dainippon Soft Capsules Drugs Product Overview
9.9.3 Sumitomo Dainippon Soft Capsules Drugs Product Market Performance
9.9.4 Sumitomo Dainippon Business Overview
9.9.5 Sumitomo Dainippon Recent Developments
9.10 Merck
9.10.1 Merck Soft Capsules Drugs Basic Information
9.10.2 Merck Soft Capsules Drugs Product Overview
9.10.3 Merck Soft Capsules Drugs Product Market Performance
9.10.4 Merck Business Overview
9.10.5 Merck Recent Developments
9.11 Atrium Innovations
9.11.1 Atrium Innovations Soft Capsules Drugs Basic Information
9.11.2 Atrium Innovations Soft Capsules Drugs Product Overview
9.11.3 Atrium Innovations Soft Capsules Drugs Product Market Performance
9.11.4 Atrium Innovations Business Overview
9.11.5 Atrium Innovations Recent Developments
9.12 Abbott
9.12.1 Abbott Soft Capsules Drugs Basic Information
9.12.2 Abbott Soft Capsules Drugs Product Overview
9.12.3 Abbott Soft Capsules Drugs Product Market Performance
9.12.4 Abbott Business Overview
9.12.5 Abbott Recent Developments
9.13 Blackmores
9.13.1 Blackmores Soft Capsules Drugs Basic Information
9.13.2 Blackmores Soft Capsules Drugs Product Overview
9.13.3 Blackmores Soft Capsules Drugs Product Market Performance
9.13.4 Blackmores Business Overview
9.13.5 Blackmores Recent Developments
9.14 The Clorox Company
9.14.1 The Clorox Company Soft Capsules Drugs Basic Information
9.14.2 The Clorox Company Soft Capsules Drugs Product Overview
9.14.3 The Clorox Company Soft Capsules Drugs Product Market Performance
9.14.4 The Clorox Company Business Overview
9.14.5 The Clorox Company Recent Developments
9.15 Nature Made
9.15.1 Nature Made Soft Capsules Drugs Basic Information
9.15.2 Nature Made Soft Capsules Drugs Product Overview
9.15.3 Nature Made Soft Capsules Drugs Product Market Performance
9.15.4 Nature Made Business Overview
9.15.5 Nature Made Recent Developments
9.16 By-health
9.16.1 By-health Soft Capsules Drugs Basic Information
9.16.2 By-health Soft Capsules Drugs Product Overview
9.16.3 By-health Soft Capsules Drugs Product Market Performance
9.16.4 By-health Business Overview
9.16.5 By-health Recent Developments
9.17 AandZ Pharmaceutical
9.17.1 AandZ Pharmaceutical Soft Capsules Drugs Basic Information
9.17.2 AandZ Pharmaceutical Soft Capsules Drugs Product Overview
9.17.3 AandZ Pharmaceutical Soft Capsules Drugs Product Market Performance
9.17.4 AandZ Pharmaceutical Business Overview
9.17.5 AandZ Pharmaceutical Recent Developments
10 SOFT CAPSULES DRUGS MARKET FORECAST BY REGION
10.1 Global Soft Capsules Drugs Market Size Forecast
10.2 Global Soft Capsules Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Soft Capsules Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Soft Capsules Drugs Market Size Forecast by Region
10.2.4 South America Soft Capsules Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Soft Capsules Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Soft Capsules Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Soft Capsules Drugs by Type (2025-2030)
11.1.2 Global Soft Capsules Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Soft Capsules Drugs by Type (2025-2030)
11.2 Global Soft Capsules Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Soft Capsules Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Soft Capsules Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Soft Capsules Drugs
1.2 Key Market Segments
1.2.1 Soft Capsules Drugs Segment by Type
1.2.2 Soft Capsules Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SOFT CAPSULES DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Soft Capsules Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Soft Capsules Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SOFT CAPSULES DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Soft Capsules Drugs Sales by Manufacturers (2019-2024)
3.2 Global Soft Capsules Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Soft Capsules Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Soft Capsules Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Soft Capsules Drugs Sales Sites, Area Served, Product Type
3.6 Soft Capsules Drugs Market Competitive Situation and Trends
3.6.1 Soft Capsules Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Soft Capsules Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 SOFT CAPSULES DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Soft Capsules Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SOFT CAPSULES DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 SOFT CAPSULES DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Soft Capsules Drugs Sales Market Share by Type (2019-2024)
6.3 Global Soft Capsules Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Soft Capsules Drugs Price by Type (2019-2024)
7 SOFT CAPSULES DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Soft Capsules Drugs Market Sales by Application (2019-2024)
7.3 Global Soft Capsules Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Soft Capsules Drugs Sales Growth Rate by Application (2019-2024)
8 SOFT CAPSULES DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Soft Capsules Drugs Sales by Region
8.1.1 Global Soft Capsules Drugs Sales by Region
8.1.2 Global Soft Capsules Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Soft Capsules Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Soft Capsules Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Soft Capsules Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Soft Capsules Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Soft Capsules Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GSK
9.1.1 GSK Soft Capsules Drugs Basic Information
9.1.2 GSK Soft Capsules Drugs Product Overview
9.1.3 GSK Soft Capsules Drugs Product Market Performance
9.1.4 GSK Business Overview
9.1.5 GSK Soft Capsules Drugs SWOT Analysis
9.1.6 GSK Recent Developments
9.2 AstraZeneca
9.2.1 AstraZeneca Soft Capsules Drugs Basic Information
9.2.2 AstraZeneca Soft Capsules Drugs Product Overview
9.2.3 AstraZeneca Soft Capsules Drugs Product Market Performance
9.2.4 AstraZeneca Business Overview
9.2.5 AstraZeneca Soft Capsules Drugs SWOT Analysis
9.2.6 AstraZeneca Recent Developments
9.3 Boehringer Ingelheim
9.3.1 Boehringer Ingelheim Soft Capsules Drugs Basic Information
9.3.2 Boehringer Ingelheim Soft Capsules Drugs Product Overview
9.3.3 Boehringer Ingelheim Soft Capsules Drugs Product Market Performance
9.3.4 Boehringer Ingelheim Soft Capsules Drugs SWOT Analysis
9.3.5 Boehringer Ingelheim Business Overview
9.3.6 Boehringer Ingelheim Recent Developments
9.4 Vertex
9.4.1 Vertex Soft Capsules Drugs Basic Information
9.4.2 Vertex Soft Capsules Drugs Product Overview
9.4.3 Vertex Soft Capsules Drugs Product Market Performance
9.4.4 Vertex Business Overview
9.4.5 Vertex Recent Developments
9.5 Roche
9.5.1 Roche Soft Capsules Drugs Basic Information
9.5.2 Roche Soft Capsules Drugs Product Overview
9.5.3 Roche Soft Capsules Drugs Product Market Performance
9.5.4 Roche Business Overview
9.5.5 Roche Recent Developments
9.6 Novartis
9.6.1 Novartis Soft Capsules Drugs Basic Information
9.6.2 Novartis Soft Capsules Drugs Product Overview
9.6.3 Novartis Soft Capsules Drugs Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 Teva
9.7.1 Teva Soft Capsules Drugs Basic Information
9.7.2 Teva Soft Capsules Drugs Product Overview
9.7.3 Teva Soft Capsules Drugs Product Market Performance
9.7.4 Teva Business Overview
9.7.5 Teva Recent Developments
9.8 Chiesi
9.8.1 Chiesi Soft Capsules Drugs Basic Information
9.8.2 Chiesi Soft Capsules Drugs Product Overview
9.8.3 Chiesi Soft Capsules Drugs Product Market Performance
9.8.4 Chiesi Business Overview
9.8.5 Chiesi Recent Developments
9.9 Sumitomo Dainippon
9.9.1 Sumitomo Dainippon Soft Capsules Drugs Basic Information
9.9.2 Sumitomo Dainippon Soft Capsules Drugs Product Overview
9.9.3 Sumitomo Dainippon Soft Capsules Drugs Product Market Performance
9.9.4 Sumitomo Dainippon Business Overview
9.9.5 Sumitomo Dainippon Recent Developments
9.10 Merck
9.10.1 Merck Soft Capsules Drugs Basic Information
9.10.2 Merck Soft Capsules Drugs Product Overview
9.10.3 Merck Soft Capsules Drugs Product Market Performance
9.10.4 Merck Business Overview
9.10.5 Merck Recent Developments
9.11 Atrium Innovations
9.11.1 Atrium Innovations Soft Capsules Drugs Basic Information
9.11.2 Atrium Innovations Soft Capsules Drugs Product Overview
9.11.3 Atrium Innovations Soft Capsules Drugs Product Market Performance
9.11.4 Atrium Innovations Business Overview
9.11.5 Atrium Innovations Recent Developments
9.12 Abbott
9.12.1 Abbott Soft Capsules Drugs Basic Information
9.12.2 Abbott Soft Capsules Drugs Product Overview
9.12.3 Abbott Soft Capsules Drugs Product Market Performance
9.12.4 Abbott Business Overview
9.12.5 Abbott Recent Developments
9.13 Blackmores
9.13.1 Blackmores Soft Capsules Drugs Basic Information
9.13.2 Blackmores Soft Capsules Drugs Product Overview
9.13.3 Blackmores Soft Capsules Drugs Product Market Performance
9.13.4 Blackmores Business Overview
9.13.5 Blackmores Recent Developments
9.14 The Clorox Company
9.14.1 The Clorox Company Soft Capsules Drugs Basic Information
9.14.2 The Clorox Company Soft Capsules Drugs Product Overview
9.14.3 The Clorox Company Soft Capsules Drugs Product Market Performance
9.14.4 The Clorox Company Business Overview
9.14.5 The Clorox Company Recent Developments
9.15 Nature Made
9.15.1 Nature Made Soft Capsules Drugs Basic Information
9.15.2 Nature Made Soft Capsules Drugs Product Overview
9.15.3 Nature Made Soft Capsules Drugs Product Market Performance
9.15.4 Nature Made Business Overview
9.15.5 Nature Made Recent Developments
9.16 By-health
9.16.1 By-health Soft Capsules Drugs Basic Information
9.16.2 By-health Soft Capsules Drugs Product Overview
9.16.3 By-health Soft Capsules Drugs Product Market Performance
9.16.4 By-health Business Overview
9.16.5 By-health Recent Developments
9.17 AandZ Pharmaceutical
9.17.1 AandZ Pharmaceutical Soft Capsules Drugs Basic Information
9.17.2 AandZ Pharmaceutical Soft Capsules Drugs Product Overview
9.17.3 AandZ Pharmaceutical Soft Capsules Drugs Product Market Performance
9.17.4 AandZ Pharmaceutical Business Overview
9.17.5 AandZ Pharmaceutical Recent Developments
10 SOFT CAPSULES DRUGS MARKET FORECAST BY REGION
10.1 Global Soft Capsules Drugs Market Size Forecast
10.2 Global Soft Capsules Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Soft Capsules Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Soft Capsules Drugs Market Size Forecast by Region
10.2.4 South America Soft Capsules Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Soft Capsules Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Soft Capsules Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Soft Capsules Drugs by Type (2025-2030)
11.1.2 Global Soft Capsules Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Soft Capsules Drugs by Type (2025-2030)
11.2 Global Soft Capsules Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Soft Capsules Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Soft Capsules Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Soft Capsules Drugs Market Size Comparison by Region (M USD)
Table 5. Global Soft Capsules Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Soft Capsules Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Soft Capsules Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Soft Capsules Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Capsules Drugs as of 2022)
Table 10. Global Market Soft Capsules Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Soft Capsules Drugs Sales Sites and Area Served
Table 12. Manufacturers Soft Capsules Drugs Product Type
Table 13. Global Soft Capsules Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Soft Capsules Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Soft Capsules Drugs Market Challenges
Table 22. Global Soft Capsules Drugs Sales by Type (Kilotons)
Table 23. Global Soft Capsules Drugs Market Size by Type (M USD)
Table 24. Global Soft Capsules Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Soft Capsules Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Soft Capsules Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Soft Capsules Drugs Market Size Share by Type (2019-2024)
Table 28. Global Soft Capsules Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Soft Capsules Drugs Sales (Kilotons) by Application
Table 30. Global Soft Capsules Drugs Market Size by Application
Table 31. Global Soft Capsules Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Soft Capsules Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Soft Capsules Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Soft Capsules Drugs Market Share by Application (2019-2024)
Table 35. Global Soft Capsules Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Soft Capsules Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Soft Capsules Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Soft Capsules Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Soft Capsules Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Soft Capsules Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Soft Capsules Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Soft Capsules Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. GSK Soft Capsules Drugs Basic Information
Table 44. GSK Soft Capsules Drugs Product Overview
Table 45. GSK Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. GSK Business Overview
Table 47. GSK Soft Capsules Drugs SWOT Analysis
Table 48. GSK Recent Developments
Table 49. AstraZeneca Soft Capsules Drugs Basic Information
Table 50. AstraZeneca Soft Capsules Drugs Product Overview
Table 51. AstraZeneca Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Soft Capsules Drugs SWOT Analysis
Table 54. AstraZeneca Recent Developments
Table 55. Boehringer Ingelheim Soft Capsules Drugs Basic Information
Table 56. Boehringer Ingelheim Soft Capsules Drugs Product Overview
Table 57. Boehringer Ingelheim Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Boehringer Ingelheim Soft Capsules Drugs SWOT Analysis
Table 59. Boehringer Ingelheim Business Overview
Table 60. Boehringer Ingelheim Recent Developments
Table 61. Vertex Soft Capsules Drugs Basic Information
Table 62. Vertex Soft Capsules Drugs Product Overview
Table 63. Vertex Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Vertex Business Overview
Table 65. Vertex Recent Developments
Table 66. Roche Soft Capsules Drugs Basic Information
Table 67. Roche Soft Capsules Drugs Product Overview
Table 68. Roche Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Roche Business Overview
Table 70. Roche Recent Developments
Table 71. Novartis Soft Capsules Drugs Basic Information
Table 72. Novartis Soft Capsules Drugs Product Overview
Table 73. Novartis Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Novartis Business Overview
Table 75. Novartis Recent Developments
Table 76. Teva Soft Capsules Drugs Basic Information
Table 77. Teva Soft Capsules Drugs Product Overview
Table 78. Teva Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Teva Business Overview
Table 80. Teva Recent Developments
Table 81. Chiesi Soft Capsules Drugs Basic Information
Table 82. Chiesi Soft Capsules Drugs Product Overview
Table 83. Chiesi Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Chiesi Business Overview
Table 85. Chiesi Recent Developments
Table 86. Sumitomo Dainippon Soft Capsules Drugs Basic Information
Table 87. Sumitomo Dainippon Soft Capsules Drugs Product Overview
Table 88. Sumitomo Dainippon Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Sumitomo Dainippon Business Overview
Table 90. Sumitomo Dainippon Recent Developments
Table 91. Merck Soft Capsules Drugs Basic Information
Table 92. Merck Soft Capsules Drugs Product Overview
Table 93. Merck Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Merck Business Overview
Table 95. Merck Recent Developments
Table 96. Atrium Innovations Soft Capsules Drugs Basic Information
Table 97. Atrium Innovations Soft Capsules Drugs Product Overview
Table 98. Atrium Innovations Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Atrium Innovations Business Overview
Table 100. Atrium Innovations Recent Developments
Table 101. Abbott Soft Capsules Drugs Basic Information
Table 102. Abbott Soft Capsules Drugs Product Overview
Table 103. Abbott Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Abbott Business Overview
Table 105. Abbott Recent Developments
Table 106. Blackmores Soft Capsules Drugs Basic Information
Table 107. Blackmores Soft Capsules Drugs Product Overview
Table 108. Blackmores Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Blackmores Business Overview
Table 110. Blackmores Recent Developments
Table 111. The Clorox Company Soft Capsules Drugs Basic Information
Table 112. The Clorox Company Soft Capsules Drugs Product Overview
Table 113. The Clorox Company Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. The Clorox Company Business Overview
Table 115. The Clorox Company Recent Developments
Table 116. Nature Made Soft Capsules Drugs Basic Information
Table 117. Nature Made Soft Capsules Drugs Product Overview
Table 118. Nature Made Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Nature Made Business Overview
Table 120. Nature Made Recent Developments
Table 121. By-health Soft Capsules Drugs Basic Information
Table 122. By-health Soft Capsules Drugs Product Overview
Table 123. By-health Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. By-health Business Overview
Table 125. By-health Recent Developments
Table 126. AandZ Pharmaceutical Soft Capsules Drugs Basic Information
Table 127. AandZ Pharmaceutical Soft Capsules Drugs Product Overview
Table 128. AandZ Pharmaceutical Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. AandZ Pharmaceutical Business Overview
Table 130. AandZ Pharmaceutical Recent Developments
Table 131. Global Soft Capsules Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 132. Global Soft Capsules Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Soft Capsules Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 134. North America Soft Capsules Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Soft Capsules Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 136. Europe Soft Capsules Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Soft Capsules Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 138. Asia Pacific Soft Capsules Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Soft Capsules Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 140. South America Soft Capsules Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Soft Capsules Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Soft Capsules Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Soft Capsules Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 144. Global Soft Capsules Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Soft Capsules Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 146. Global Soft Capsules Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 147. Global Soft Capsules Drugs Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Soft Capsules Drugs Market Size Comparison by Region (M USD)
Table 5. Global Soft Capsules Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Soft Capsules Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Soft Capsules Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Soft Capsules Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Capsules Drugs as of 2022)
Table 10. Global Market Soft Capsules Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Soft Capsules Drugs Sales Sites and Area Served
Table 12. Manufacturers Soft Capsules Drugs Product Type
Table 13. Global Soft Capsules Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Soft Capsules Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Soft Capsules Drugs Market Challenges
Table 22. Global Soft Capsules Drugs Sales by Type (Kilotons)
Table 23. Global Soft Capsules Drugs Market Size by Type (M USD)
Table 24. Global Soft Capsules Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Soft Capsules Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Soft Capsules Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Soft Capsules Drugs Market Size Share by Type (2019-2024)
Table 28. Global Soft Capsules Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Soft Capsules Drugs Sales (Kilotons) by Application
Table 30. Global Soft Capsules Drugs Market Size by Application
Table 31. Global Soft Capsules Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Soft Capsules Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Soft Capsules Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Soft Capsules Drugs Market Share by Application (2019-2024)
Table 35. Global Soft Capsules Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Soft Capsules Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Soft Capsules Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Soft Capsules Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Soft Capsules Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Soft Capsules Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Soft Capsules Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Soft Capsules Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. GSK Soft Capsules Drugs Basic Information
Table 44. GSK Soft Capsules Drugs Product Overview
Table 45. GSK Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. GSK Business Overview
Table 47. GSK Soft Capsules Drugs SWOT Analysis
Table 48. GSK Recent Developments
Table 49. AstraZeneca Soft Capsules Drugs Basic Information
Table 50. AstraZeneca Soft Capsules Drugs Product Overview
Table 51. AstraZeneca Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Soft Capsules Drugs SWOT Analysis
Table 54. AstraZeneca Recent Developments
Table 55. Boehringer Ingelheim Soft Capsules Drugs Basic Information
Table 56. Boehringer Ingelheim Soft Capsules Drugs Product Overview
Table 57. Boehringer Ingelheim Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Boehringer Ingelheim Soft Capsules Drugs SWOT Analysis
Table 59. Boehringer Ingelheim Business Overview
Table 60. Boehringer Ingelheim Recent Developments
Table 61. Vertex Soft Capsules Drugs Basic Information
Table 62. Vertex Soft Capsules Drugs Product Overview
Table 63. Vertex Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Vertex Business Overview
Table 65. Vertex Recent Developments
Table 66. Roche Soft Capsules Drugs Basic Information
Table 67. Roche Soft Capsules Drugs Product Overview
Table 68. Roche Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Roche Business Overview
Table 70. Roche Recent Developments
Table 71. Novartis Soft Capsules Drugs Basic Information
Table 72. Novartis Soft Capsules Drugs Product Overview
Table 73. Novartis Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Novartis Business Overview
Table 75. Novartis Recent Developments
Table 76. Teva Soft Capsules Drugs Basic Information
Table 77. Teva Soft Capsules Drugs Product Overview
Table 78. Teva Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Teva Business Overview
Table 80. Teva Recent Developments
Table 81. Chiesi Soft Capsules Drugs Basic Information
Table 82. Chiesi Soft Capsules Drugs Product Overview
Table 83. Chiesi Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Chiesi Business Overview
Table 85. Chiesi Recent Developments
Table 86. Sumitomo Dainippon Soft Capsules Drugs Basic Information
Table 87. Sumitomo Dainippon Soft Capsules Drugs Product Overview
Table 88. Sumitomo Dainippon Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Sumitomo Dainippon Business Overview
Table 90. Sumitomo Dainippon Recent Developments
Table 91. Merck Soft Capsules Drugs Basic Information
Table 92. Merck Soft Capsules Drugs Product Overview
Table 93. Merck Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Merck Business Overview
Table 95. Merck Recent Developments
Table 96. Atrium Innovations Soft Capsules Drugs Basic Information
Table 97. Atrium Innovations Soft Capsules Drugs Product Overview
Table 98. Atrium Innovations Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Atrium Innovations Business Overview
Table 100. Atrium Innovations Recent Developments
Table 101. Abbott Soft Capsules Drugs Basic Information
Table 102. Abbott Soft Capsules Drugs Product Overview
Table 103. Abbott Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Abbott Business Overview
Table 105. Abbott Recent Developments
Table 106. Blackmores Soft Capsules Drugs Basic Information
Table 107. Blackmores Soft Capsules Drugs Product Overview
Table 108. Blackmores Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Blackmores Business Overview
Table 110. Blackmores Recent Developments
Table 111. The Clorox Company Soft Capsules Drugs Basic Information
Table 112. The Clorox Company Soft Capsules Drugs Product Overview
Table 113. The Clorox Company Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. The Clorox Company Business Overview
Table 115. The Clorox Company Recent Developments
Table 116. Nature Made Soft Capsules Drugs Basic Information
Table 117. Nature Made Soft Capsules Drugs Product Overview
Table 118. Nature Made Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Nature Made Business Overview
Table 120. Nature Made Recent Developments
Table 121. By-health Soft Capsules Drugs Basic Information
Table 122. By-health Soft Capsules Drugs Product Overview
Table 123. By-health Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. By-health Business Overview
Table 125. By-health Recent Developments
Table 126. AandZ Pharmaceutical Soft Capsules Drugs Basic Information
Table 127. AandZ Pharmaceutical Soft Capsules Drugs Product Overview
Table 128. AandZ Pharmaceutical Soft Capsules Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. AandZ Pharmaceutical Business Overview
Table 130. AandZ Pharmaceutical Recent Developments
Table 131. Global Soft Capsules Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 132. Global Soft Capsules Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America Soft Capsules Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 134. North America Soft Capsules Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe Soft Capsules Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 136. Europe Soft Capsules Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific Soft Capsules Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 138. Asia Pacific Soft Capsules Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America Soft Capsules Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 140. South America Soft Capsules Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa Soft Capsules Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa Soft Capsules Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global Soft Capsules Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 144. Global Soft Capsules Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global Soft Capsules Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 146. Global Soft Capsules Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 147. Global Soft Capsules Drugs Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Soft Capsules Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Soft Capsules Drugs Market Size (M USD), 2019-2030
Figure 5. Global Soft Capsules Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Soft Capsules Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Soft Capsules Drugs Market Size by Country (M USD)
Figure 11. Soft Capsules Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Soft Capsules Drugs Revenue Share by Manufacturers in 2023
Figure 13. Soft Capsules Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Soft Capsules Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Soft Capsules Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Soft Capsules Drugs Market Share by Type
Figure 18. Sales Market Share of Soft Capsules Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Soft Capsules Drugs by Type in 2023
Figure 20. Market Size Share of Soft Capsules Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Soft Capsules Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Soft Capsules Drugs Market Share by Application
Figure 24. Global Soft Capsules Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Soft Capsules Drugs Sales Market Share by Application in 2023
Figure 26. Global Soft Capsules Drugs Market Share by Application (2019-2024)
Figure 27. Global Soft Capsules Drugs Market Share by Application in 2023
Figure 28. Global Soft Capsules Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Soft Capsules Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Soft Capsules Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Soft Capsules Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Soft Capsules Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Soft Capsules Drugs Sales Market Share by Country in 2023
Figure 37. Germany Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Soft Capsules Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Soft Capsules Drugs Sales Market Share by Region in 2023
Figure 44. China Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Soft Capsules Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Soft Capsules Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Soft Capsules Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Soft Capsules Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Soft Capsules Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Soft Capsules Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Soft Capsules Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Soft Capsules Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Soft Capsules Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Soft Capsules Drugs Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Soft Capsules Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Soft Capsules Drugs Market Size (M USD), 2019-2030
Figure 5. Global Soft Capsules Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Soft Capsules Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Soft Capsules Drugs Market Size by Country (M USD)
Figure 11. Soft Capsules Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Soft Capsules Drugs Revenue Share by Manufacturers in 2023
Figure 13. Soft Capsules Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Soft Capsules Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Soft Capsules Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Soft Capsules Drugs Market Share by Type
Figure 18. Sales Market Share of Soft Capsules Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Soft Capsules Drugs by Type in 2023
Figure 20. Market Size Share of Soft Capsules Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Soft Capsules Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Soft Capsules Drugs Market Share by Application
Figure 24. Global Soft Capsules Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Soft Capsules Drugs Sales Market Share by Application in 2023
Figure 26. Global Soft Capsules Drugs Market Share by Application (2019-2024)
Figure 27. Global Soft Capsules Drugs Market Share by Application in 2023
Figure 28. Global Soft Capsules Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Soft Capsules Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Soft Capsules Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Soft Capsules Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Soft Capsules Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Soft Capsules Drugs Sales Market Share by Country in 2023
Figure 37. Germany Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Soft Capsules Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Soft Capsules Drugs Sales Market Share by Region in 2023
Figure 44. China Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Soft Capsules Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Soft Capsules Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Soft Capsules Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Soft Capsules Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Soft Capsules Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Soft Capsules Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Soft Capsules Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Soft Capsules Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Soft Capsules Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Soft Capsules Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Soft Capsules Drugs Market Share Forecast by Application (2025-2030)
